Join a leading team driving innovative health economic and outcomes research. Leverage your expertise to influence drug development and healthcare delivery, ensuring robust evidence generation and strategic partnerships across cross-functional teams.

Join a team that's redefining health outcomes research by leading HEOR strategy, developing robust evidence generation, and collaborating across functions to improve patient access and outcomes in the cardiometabolic health domain.

Drive global market access strategy for gene therapies, ensuring cohesive pricing, contracting, and innovative payment models across ultra-rare and common disease assets. Collaborate with cross-functional teams to optimize market positioning and outcomes.

Contribute to impactful model-based decision-making and scientific leadership in PK/PD across the drug development portfolio, collaborating with diverse teams to inform strategic dose and patient population choices for innovative medicines.

Unlock potential by leading global market access strategies to enhance gene therapy portfolios, ensuring innovative pricing, payment models, and consistency across markets while aligning with key stakeholders and shaping external policy frameworks.